Posted: August 22nd, 2011 in Miscellaneous
Scientists say new insights into a common tuberculosis drug will make it possible to shorten the treatment period for patients infected with TB. The drug "pyrazinamide" is widely used in combination with other drugs to treat active tuberculosis infections. Now, doctors are learning more about how it works - and calling the new information a "breakthrough."